Global Medical REIT Inc. (GMRE)
NYSE: GMRE · Real-Time Price · USD
32.35
-0.34 (-1.04%)
Dec 5, 2025, 4:00 PM EST - Market closed

Company Description

Global Medical REIT Inc. (the “Company”) is a Maryland corporation and internally managed real estate investment trust (“REIT”) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

The Company holds its facilities and conducts its operations through a Delaware limited partnership subsidiary, Global Medical REIT L.P. (the “Operating Partnership”).

The Company serves as the sole general partner of the Operating Partnership through a wholly owned subsidiary of the Company, Global Medical REIT GP LLC, a Delaware limited liability company.

As of September 30, 2025, the Company was the 92.14% limited partner of the Operating Partnership, with an aggregate of 7.86% of the Operating Partnership owned by holders of long-term incentive plan units (“LTIP Units”) and third-party limited partners who contributed properties or services to the Operating Partnership in exchange for common limited partnership units (“OP Units”).

Global Medical REIT Inc.
Global Medical REIT logo
Country United States
Founded 2011
Industry REIT - Healthcare Facilities
Sector Real Estate
Employees 26
CEO Mark Decker

Contact Details

Address:
7373 Wisconsin Avenue, Suite 800
Bethesda, Maryland 20814
United States
Phone 202 524 6851
Website globalmedicalreit.com

Stock Details

Ticker Symbol GMRE
Exchange NYSE
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001533615
CUSIP Number 37954A204
ISIN Number US37954A3032
Employer ID 46-4757266
SIC Code 6798

Key Executives

Name Position
Mark O. Decker Jr. President, Chief Executive Officer and Director
Robert J. Kiernan CPA Chief Financial Officer and Treasurer
Danica C. Holley Chief Operating Officer
Alfonzo Leon Chief Investment Officer
Jamie A. Barber J.D. General Counsel and Corporate Secretary
Stephen C. Swett Investor Relations Executive

Latest SEC Filings

Date Type Title
Dec 4, 2025 8-K Current Report
Nov 18, 2025 CERT Certification by an exchange approving securities for listing
Nov 18, 2025 8-A12B Registration of securities
Nov 18, 2025 8-K Current Report
Nov 14, 2025 424B5 Filing
Nov 14, 2025 SCHEDULE 13G/A Filing
Nov 14, 2025 FWP Free Writing Prospectus
Nov 13, 2025 424B5 Filing
Nov 13, 2025 8-K Current Report
Nov 5, 2025 10-Q Quarterly Report